A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity

Hepatocellular carcinoma (HCC) recurrence after liver transplant is associated with a poor prognosis and significantly increases morbidity and mortality among liver transplant patients. Therefore, this meta-analysis aims to evaluate the overall prevalence of HCC recurrence following liver transplant...

Full description

Bibliographic Details
Main Authors: Darren J. H. Tan, Chloe Wong, Cheng Han Ng, Chen Wei Poh, Sneha Rajiv Jain, Daniel Q. Huang, Mark D. Muthiah
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/2/238
id doaj-1316fcc6cbe54a42a1c90c892ca297e7
record_format Article
spelling doaj-1316fcc6cbe54a42a1c90c892ca297e72021-01-12T00:02:55ZengMDPI AGJournal of Clinical Medicine2077-03832021-01-011023823810.3390/jcm10020238A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and EthnicityDarren J. H. Tan0Chloe Wong1Cheng Han Ng2Chen Wei Poh3Sneha Rajiv Jain4Daniel Q. Huang5Mark D. Muthiah6Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, SingaporeYong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, SingaporeYong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, SingaporeYong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, SingaporeYong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, SingaporeYong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, SingaporeYong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, SingaporeHepatocellular carcinoma (HCC) recurrence after liver transplant is associated with a poor prognosis and significantly increases morbidity and mortality among liver transplant patients. Therefore, this meta-analysis aims to evaluate the overall prevalence of HCC recurrence following liver transplant. Medline and Embase databases were searched, and a meta-analysis of proportions was conducted. Observational studies reporting the prevalence of recurrent hepatocellular carcinoma (HCC) after liver transplant were included, with the analysis being stratified by adherence to Milan criteria, ethnicity, socio-economic status, alpha fetoprotein (AFP) levels, living donor vs. deceased donor, and the underlying aetiology of the liver disease. A meta-regression on the date of the study completion was also performed. Of a total 40,495 patients, 3888 developed an HCC recurrence. The overall prevalence of recurrent HCC was 13% (CI: 0.12–0.15). Patients beyond the Milan criteria (MC) were more likely to recur than patients within MC. Asian populations had the greatest prevalence of HCC recurrence (19%; CI: 0.15–0.24) when compared to Western (12%; CI: 0.11–0.13) and Latin American populations (11%; CI: 0.09–0.14). The prevalence of recurrent HCC was the highest in patients infected with hepatitis B virus (HBV) (18%; CI: 0.11–0.27) compared to other aetiologies. A higher AFP also resulted in an increased recurrence. This highlights interesting differences based on ethnicity, income, and aetiology, and further studies are needed to determine the reasons for the disparity.https://www.mdpi.com/2077-0383/10/2/238deceased donor liver transplantethnicityepidemiologyHCC recurrenceliving donor liver transplantmeta-analysis
collection DOAJ
language English
format Article
sources DOAJ
author Darren J. H. Tan
Chloe Wong
Cheng Han Ng
Chen Wei Poh
Sneha Rajiv Jain
Daniel Q. Huang
Mark D. Muthiah
spellingShingle Darren J. H. Tan
Chloe Wong
Cheng Han Ng
Chen Wei Poh
Sneha Rajiv Jain
Daniel Q. Huang
Mark D. Muthiah
A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity
Journal of Clinical Medicine
deceased donor liver transplant
ethnicity
epidemiology
HCC recurrence
living donor liver transplant
meta-analysis
author_facet Darren J. H. Tan
Chloe Wong
Cheng Han Ng
Chen Wei Poh
Sneha Rajiv Jain
Daniel Q. Huang
Mark D. Muthiah
author_sort Darren J. H. Tan
title A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity
title_short A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity
title_full A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity
title_fullStr A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity
title_full_unstemmed A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity
title_sort meta-analysis on the rate of hepatocellular carcinoma recurrence after liver transplant and associations to etiology, alpha-fetoprotein, income and ethnicity
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2021-01-01
description Hepatocellular carcinoma (HCC) recurrence after liver transplant is associated with a poor prognosis and significantly increases morbidity and mortality among liver transplant patients. Therefore, this meta-analysis aims to evaluate the overall prevalence of HCC recurrence following liver transplant. Medline and Embase databases were searched, and a meta-analysis of proportions was conducted. Observational studies reporting the prevalence of recurrent hepatocellular carcinoma (HCC) after liver transplant were included, with the analysis being stratified by adherence to Milan criteria, ethnicity, socio-economic status, alpha fetoprotein (AFP) levels, living donor vs. deceased donor, and the underlying aetiology of the liver disease. A meta-regression on the date of the study completion was also performed. Of a total 40,495 patients, 3888 developed an HCC recurrence. The overall prevalence of recurrent HCC was 13% (CI: 0.12–0.15). Patients beyond the Milan criteria (MC) were more likely to recur than patients within MC. Asian populations had the greatest prevalence of HCC recurrence (19%; CI: 0.15–0.24) when compared to Western (12%; CI: 0.11–0.13) and Latin American populations (11%; CI: 0.09–0.14). The prevalence of recurrent HCC was the highest in patients infected with hepatitis B virus (HBV) (18%; CI: 0.11–0.27) compared to other aetiologies. A higher AFP also resulted in an increased recurrence. This highlights interesting differences based on ethnicity, income, and aetiology, and further studies are needed to determine the reasons for the disparity.
topic deceased donor liver transplant
ethnicity
epidemiology
HCC recurrence
living donor liver transplant
meta-analysis
url https://www.mdpi.com/2077-0383/10/2/238
work_keys_str_mv AT darrenjhtan ametaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT chloewong ametaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT chenghanng ametaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT chenweipoh ametaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT sneharajivjain ametaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT danielqhuang ametaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT markdmuthiah ametaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT darrenjhtan metaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT chloewong metaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT chenghanng metaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT chenweipoh metaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT sneharajivjain metaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT danielqhuang metaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
AT markdmuthiah metaanalysisontherateofhepatocellularcarcinomarecurrenceafterlivertransplantandassociationstoetiologyalphafetoproteinincomeandethnicity
_version_ 1724340961576747008